U
APEN

UBS’s Apollo Endosurgery, Inc. APEN Stock Holding History

UBS’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-11
Closed -$3K – 10886
2014
Q2 		$3K Buy
+11
New +$3.49K ﹤0.01% 9879
2014
Q1 		– Hold
0
– – – 10945
2013
Q4 		– Sell
-51
Closed -$18.7K – 10872
2013
Q3 		$22K Buy
51
+18
+55% +$7.88K ﹤0.01% 7955
2013
Q2 		$11K Buy
+33
New +$12.4K ﹤0.01% 8558

Other funds holding APEN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS's APEN Position: Q3 2014 in Review

UBS sold out of Apollo Endosurgery, Inc. (APEN) in Q3 2014, closing a stake of 11 shares — an estimated $3K sold.

UBS first reported a position in APEN in Q2 2013 and held it in 3 quarters. The position peaked at $22K in Q3 2013. 22 funds tracked by Wall St. Rank hold APEN as of Q3 2014.

  • UBS reported no remaining Apollo Endosurgery, Inc. position as of Q3 2014 after selling out during the quarter.
  • UBS sold 11 Apollo Endosurgery, Inc. shares in Q3 2014, an estimated $3K.
  • UBS first reported a position in Apollo Endosurgery, Inc. in Q2 2013 and held it in 3 quarters.
  • UBS's Apollo Endosurgery, Inc. position peaked at $22K in Q3 2013.
  • 22 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.